Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | PREP | P48147 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL393307 | 0.82 | ALDH1A1 (0.38) | ALDH1A1TSHRMEN1KMT2AL3MBTL1 | |
| SCHEMBL1861179 | 0.82 | ALDH1A1 (0.38) | ALDH1A1TSHRMEN1KMT2AL3MBTL1 | |
| SCHEMBL1861180 | 0.82 | ALDH1A1 (0.38) | ALDH1A1TSHRMEN1KMT2AL3MBTL1 | |
| SCHEMBL17137099 | 0.82 | ALDH1A1 (0.35) | ALDH1A1PREPATMTSHRMEN1 | |
| SCHEMBL24909113 | 0.82 | ALDH1A1 (0.35) | ALDH1A1PREPATMTSHRMEN1 | |
| SCHEMBL17137102 | 0.82 | ALDH1A1 (0.35) | ALDH1A1PREPATMTSHRMEN1 | |
| SCHEMBL611103 | 0.80 | MEN1 (0.36) | MEN1KMT2A | |
| SCHEMBL609920 | 0.79 | NR1H2 (0.41) | PREPATMMEN1KMT2ACTSK | |
| SCHEMBL31603219 | 0.79 | ALDH1A1 (0.41) | ALDH1A1ATMTSHRMEN1KMT2A | |
| SCHEMBL31457946 | 0.78 | PREP (0.38) | ALDH1A1PREPATMMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230012570-A1 | BICYCLIC COMPOUND USED AS SELECTIVE ANDROGEN RECEPTOR MODULATOR | MEDSHINE DISCOVERY INC. (CN) | 2023-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230012570-A1 | BICYCLIC COMPOUND USED AS SELECTIVE ANDROGEN RECEPTOR MODULATOR | AR, NR5A1, CYP17A1 | ALDH1A1 936/4885PREP 3801/4885ATM 2769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.